Family Medicine Doctors in Lehighton, PA Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dimitry Belogorodsky, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2226 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 610-297-3003

Dr. Peter J Baddick Iii, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2175 Blakeslee Boulevard Dr W, Lehighton, PA 18235 Phone: 570-386-4171    Fax: 570-386-2429

Daniel George Walker, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2175 Blakeslee Boulevard Dr W, Lehighton, PA 18235 Phone: 570-386-4171

David Thomas Ogurek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 N 1st St, Lehighton, PA 18235 Phone: 484-464-9510

Kenneth R Sharp, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 N 1st St, Lehighton, PA 18235 Phone: 484-464-9510    Fax: 484-464-9515

Ismat Ahmad, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 St Lukes Dr, Lehighton, PA 18235 Phone: 484-526-4500

Dennis James Kondash, D.O. Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 211 N 12th St, Lehighton, PA 18235 Phone: 610-377-7174    Fax: 610-377-4785

Priya Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 State Rd, Lehighton, PA 18235 Phone: 610-426-2050    Fax: 833-204-9597

Joseph M Mcginley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 856 Interchange Rd, Lehighton, PA 18235 Phone: 610-377-9020

News Archive

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.

Hepatectomy effective for treatment of caudate lobe HCC

Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.

QuadraMed, CPMRC partner to provide integrated EHR solution with evidence-based content

QuadraMed, a leading provider of healthcare technologies and services, and the CPM Resource Center (CPMRC), an Elsevier company and leader in developing clinical practice guidelines for healthcare, today announced their partnership to provide QuadraMed's clients with nursing and allied health clinical documentation, care planning, and clinical practice guidelines, as well as transformation services.

Read more Medical News

› Verified 7 days ago